Abstract
Neurogenic blepharoptosis is an important entity to recognize since there are specific considerations in its evaluation and treatment. Most cases are caused by lesions of the oculomotor nerve or a disruption of the oculosympathetic pathway. Neurogenic ptosis can be distinguished from involutional blepharoptosis by the associated findings of pupillary and/or ocular motility abnormalities. The etiology and localization of the lesion is determined by a careful review of the history, associated signs and symptoms, and appropriate neuroimaging studies. The initial treatment approach is aimed at correcting the underlying pathologic process. For patients who require surgical repair of the ptosis, frontalis sling is the only viable option for patients with oculomotor nerve palsy, while both levator resection and Müllerectomy are effective procedures for patients with Horner syndrome.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Caplan LR. Cerebral ptosis. J Neurol Neurosurg Psychiatry. 1974;34:1–7.
Averbuch-Heller L, Leigh RJ, Mermelstein V, Zagalsky L, Streifler JY. Ptosis in patients with hemispheric strokes. Neurology. 2002;58:620–4.
Krohel GB, Griffin JF. Cortical blepharoptosis. Am J Ophthalmol. 1978;85:632–4.
Boghen D. Apraxia of eyelid opening: a review. Neurology. 1997;48:1491–4.
Lepore FE, Duvoisin RC. “Apraxia” of eyelid opening: an involuntary levator inhibition. Neurology. 1985;35:423–7.
Jordan DR, Anderson Rl, Digre K. Apraxia of lid opening in blepharospasm. Ophthalmic Surg. 1990;21:331–4.
Richards BW, Jones FR, Younge BR. Causes and prognosis in 4278 cases of paralysis of the oculomotor, trochlear, and abducens cranial nerves. Am J Ophthalmol. 1992;113:489–96.
Carter SR, Meecham WJ, Seiff SR. Silicone frontalis slings for the correction of blepharoptosis: indications and efficacy. Ophthalmology. 1996;103(4):623–30.
Kardon RH, Denison CE, Brown CK, Thompson HS. Critical evaluation of the cocaine test in the diagnosis of Horner’s syndrome. Arch Ophthalmol. 1990;108:384–7.
Koc F, Kavuncu S, Kansu T, Acaroglu G, Firat E. The sensitivity and specificity of 0.5% apraclonidine in the diagnosis of oculosympathetic paresis. Br J Ophthalmol. 2005;89(11):1442–4.
Brown SM, Aouchiche R, Freedman KA. The utility of 0.5% apraclonidine in the diagnosis of horner syndrome. Arch Ophthalmol. 2003;121(8):1201–3.
Morales J, Brown SM, Abdul-Rahim AS, Crosson CE. Ocular effects of apraclonidine in Horner syndrome. Arch Ophthalmol. 2000;118:951–4.
Cremer SA, Thompson HS, Digre KB, Kardon RH. Hydroxyamphetamine mydriasis in Horner’s syndrome. Am J Ophthalmol. 1990;110:71–6.
Maloney WF, Younge BR, Moyer NK. Evaluation of the causes and accuracy of pharmacologic location of Horner’s syndrome. Am J Ophthalmol. 1980;90:394–402.
Kline LB, Vitek JJ, Raymon BC. Painful Horner’s syndrome due to spontaneous carotid artery dissection. Ophthalmology. 1987;94:226–30.
Jeffery AR, Ellis FJ, Repka MX, Buncic JR. Pediatric Horner syndrome. J AAPOS. 1998;2:159–67.
Watts P, Satterfirld D, Lim MK. Adverse effects of apraclonidine used in the diagnosis of Horner syndrome in infants. J AAPOS. 2007;11(3):282–3.
George ND, Gonzalez G, Hoyt CS. Does Horner’s syndrome in infancy require investigation? Br J Ophthalmol. 1998;82:51–4.
Musarella MA, Chan HS, DeBoer G, Gallie BL. Ocular involvement in neuroblastoma: prognostic implications. Ophthalmology. 1984;91:936–40.
Mahoney NR, Liu GT, Menacker SJ, Wilson MC, Hogarty MD, Maris JM. Pediatric Horner syndrome: etiologies and roles of imaging and urine studies to detect neuroblastoma and other responsible mass lesions. Am J Ophthalmol. 2006;142:651–9.
Glatt HJ, Putterman AM, Fett DR. Müller’s muscle-conjunctival resection procedure in the treatment of ptosis in Horner’s syndrome. Ophthalmic Surg. 1990;21(2):93–6.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Kim, J.W. (2011). Neurogenic Blepharoptosis. In: Cohen, A., Weinberg, D. (eds) Evaluation and Management of Blepharoptosis. Springer, New York, NY. https://doi.org/10.1007/978-0-387-92855-5_12
Download citation
DOI: https://doi.org/10.1007/978-0-387-92855-5_12
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-92854-8
Online ISBN: 978-0-387-92855-5
eBook Packages: MedicineMedicine (R0)